Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Diagnosing Mantle-Cell Lymphoma

Web Exclusives

Mantle-cell lymphoma (MCL) is 1 of approximately 70 subtypes of non-Hodgkin lymphoma (NHL),1 and patients who have a potential diagnosis of MCL need to make sure their subtype has been correctly identified. This is critical, because the choice of treatment can be different depending on the subtype.

Common signs and symptoms of MCL may include 1 or more of the following1,2:

  • Swelling of lymph nodes in the neck, armpits, or groin area
  • Abdominal pain or bloating
  • Fever
  • Recurring night sweats
  • Feeling very tired
  • Itching or rash
  • Swollen tonsils
  • Loss of appetite and unexplained weight loss
  • Nausea and/or vomiting.

Many other diseases cause similar symptoms; therefore, making a definitive diagnosis can be challenging. To diagnose MCL, a doctor conducts a surgical biopsy to remove an enlarged lymph node and check it for lymphoma cells.1

If the physician suspects MCL, the initial workup will include a careful physical examination, with close attention paid to lymph node areas, to look for the presence of lymphoma symptoms.1 The physician will typically order a laboratory assessment that includes a complete blood count, chemistry profile, and measurement of serum lactate dehydrogenase.3

If MCL is confirmed, additional tests and scans will be done to determine how many groups of lymph nodes are affected and whether the lymphoma has spread. This may also include a bone marrow evaluation and PET scans of the chest, abdomen, and pelvis.3

These tests are needed to identify the stage of the disease. MCL, like other subtypes of NHL, is staged, or categorized, as low grade (meaning that it is slow-growing) or high grade (fast-growing). Staging is important, because it can help guide your physician to recommend the best possible treatment option.4

References

  1. Leukemia & Lymphoma Society. Mantle cell lymphoma. www.lls.org/sites/default/files/file_assets/FS4_MCL_Facts_2018-final.pdf. Accessed March 1, 2019.
  2. Lymphoma News Today. Mantle cell lymphoma: what you need to know. https://lymphomanewstoday.com/mantle-cell-lymphoma. Accessed March 1, 2019.
  3. Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management. Am J Hematol. 2017;92:806-813.
  4. Cancer Research UK. Mantle cell lymphoma. www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/types/mantle-cell. Last reviewed February 1, 2018. Accessed March 1, 2019.

Recommended For You